UltreonTM 3.0
Software

Proven by Data.
Powered by Intelligence.

Ultreon 3.0 Software

Imaging Reimagined with Ultreon™ 3.0 Software

High-resolution OCT imaging with physiology and AI-automated insights to enable simple, fast, and precise decisions for complex cases.

Delivers low-to-zero contrast OCT imaging at higher resolution than IVUS1

One-second Pullback

  • Fast Pullback with streamlined setup and Al automated insights simplifies workflow
  • Enables saline compatibility for renal risk patients

Ultreon 3.0 low to zero contrast OCT imaging

One Pullback, Total Perspective: Optimize flow recovery and predict PCI outcomes with FFROCT

Pre-PCI to Post-PCI

FFROCT to optimize PCI

Evaluate the degree of ischemia for each lesion

FFR OCT to optimize PCI

Target FFROCT 

Compare the physiologic impact of different treatment plans in real time

Target FFR OCT

Post-PCI FFROCT

Predict patient outcomes, independent of MSA

Post-PCI FFR OCT

Ultreon™ 3.0 Software with FFROCT is backed by data

82%
ACCURACY

Fusion Study

 FFROCT demonstrated high accuracy compared to wire-based FFR2

0.70
HAZARD RATIO

FFROCT per 0.1 mm Hg/mm Hg p=0.021

Illumien IV Substudy

Post-PCI FFROCT assessment is predictive of 2-year clinical outcomes independent of MSA

Insights in seconds for faster procedure planning

Calcium

Arc and thickness automatically highlighted (orange) and measured

Measured Calcium

Lipid detection

Automatic detection (blue) helps you easily identify lipid-free landing zones

Lipid detection

EEL

Automatically highlighted (dashed white line) and measured

EEL detection

Automatic tri-registration

  • Tri-registration of angiography, OCT, and physiology data
  • Enables users to pinpoint the angiographic location of calcium, lipid, and FFROCT

automatic tri-registration of angiography, OCT, and phsyiology data

References

*FFROCT is the commercial name for Virtual Flow Reserve (VFR).

**Compared to previous Ultreon™ Software generations.

Ultreon™ 3.0 Software for OPTIS™ Next Imaging Systems Instructions for Use (IFU). Refer to IFU for additional information. 

  1. Maehara A, Matsumura M, Ali ZA, et al. IVUS-Guided Versus OCT-Guided Coronary Stent Implantation: A Critical Appraisal. JACC: Cardiovascular Imaging. 2017;10(12):1487-1503. 
  2. Jeremias A, et al. Optical Coherence Tomography–Based Functional Stenosis Assessment: FUSION—A Prospective Multicenter Trial. Circ Cardiovasc Interv. 2024:17:e013702. 
  3. Johnson TW, et al. Impact of Optical Coherence Tomography-Based Post-PCI Physiology Assessment to Predict Clinical Outcomes: An ILUMIEN-IV Substudy. J Am Coll Cardiol. 2025 Jul 15;86(2):93-102.

MAT-2512693 v1.0